Mednow Inc Stock Last Dividend Paid
| MDNWF Stock | USD 0.02 0.00 0.00% |
Mednow Inc fundamentals help investors to digest information that contributes to Mednow's financial success or failures. It also enables traders to predict the movement of Mednow Pink Sheet. The fundamental analysis module provides a way to measure Mednow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednow pink sheet.
Mednow |
Mednow Inc Company Last Dividend Paid Analysis
Mednow's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Mednow Inc has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Health Information Services (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Mednow Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednow's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mednow could also be used in its relative valuation, which is a method of valuing Mednow by comparing valuation metrics of similar companies.Mednow is currently under evaluation in last dividend paid category among its peers.
Mednow Fundamentals
| Return On Equity | -1.9 | |||
| Return On Asset | -0.55 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 4.96 M | |||
| Shares Outstanding | 21.57 M | |||
| Shares Owned By Insiders | 47.93 % | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 16.64 M | |||
| Gross Profit | 2.78 M | |||
| EBITDA | (28.12 M) | |||
| Net Income | (29.56 M) | |||
| Cash And Equivalents | 9.39 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 30 K | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (16.09 M) | |||
| Earnings Per Share | (0.71) X | |||
| Market Capitalization | 10.33 M | |||
| Total Asset | 18.13 M | |||
| Net Asset | 18.13 M |
About Mednow Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednow Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednow Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Mednow Pink Sheet
Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.